Preventing Respiratory Tract Disease in Newborns: ‘Abrysvo’ Immunization by Pfizer

2023-08-22 11:52:33

Microbiology and Infectious Diseases – ‘Abrysvo’, from Pfizer

Its administration between weeks 32 and 36 prevents severe lower respiratory tract disease in babies in their first three months of life by more than 90%.

Immunization of pregnant women once morest RSV has shown great benefit for babies.
1692707177
#approves #RSV #vaccine #pregnant #women